查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2034921

全球左心耳封堵器市場：市場規模、佔有率和趨勢分析（2026-2032 年）

Left Atrial Appendage Closure Device Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Endocardial, Epicardial, and 1 Other Device Market
出版日期: | 出版商: iData Research Inc. | 英文 102 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球左心耳封堵器市場報告（至2032年）

2025年全球左心耳封堵器市場規模為23億美元。預計到2032年，該市場將以10.5%的複合年成長率成長，達到46億美元。

本報告涵蓋了左心耳（LAA）封堵裝置的全球市場，包括心內膜和心外膜左心耳封堵技術。

分析內容包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長的促進因素包括：人們對喉心房封堵術（LAA）相關血栓風險的認知不斷提高；識別血栓性栓塞症的準確性不斷提高；以及使用器械進行LAA封堵術的普及率不斷上升。然而，該手術的複雜性以及對術者技能的高度依賴，仍然限制了其在病例量較小的醫療機構和新興醫療市場的應用。

市場概覽

全球左心耳封堵器市場包括用於封堵或阻斷左心耳的裝置，左心耳是左心房內的一個囊狀小結構，與心房顫動患者的血栓形成有關。

左心耳封堵術用於降低某些患者的血栓性栓塞症風險。對於患有心房顫動且中風風險高、不適合長期抗凝血治療的患者而言，這些裝置尤其重要。

該市場包括心內膜裝置和心外膜裝置。心內膜裝置經由導管從心臟內部植入，而心外膜裝置則從心臟外部封閉或阻塞左心耳。

左心耳封堵器市場成長的促進因素是，對存在左心耳血栓形成風險的心房顫動患者進行精準識別的能力不斷提高。雖然心內膜和心外膜封堵器的使用量預計都會增加，但由於心內膜左心耳封堵器應用更廣泛且手術創傷更小，預計其將佔據市場成長的大部分佔有率。

市場促進因素

辨識左心耳（LAA）

人們對左心耳及其在血栓性栓塞症風險中的作用認知不斷提高，是左心耳封堵器市場的主要驅動力。隨著手術數量的增加，人們對左心耳管理和現有治療方案的認知預計也會提高。

WATCHMAN™裝置在左心耳封堵術方面獲得了積極的回饋，並提高了醫生、醫院和患者的認知度。預計這種認知度的提高將惠及所有擁有臨床數據支持其有效性的左心耳封堵裝置。

隨著大眾意識的提高，越來越多的心房顫動患者可能會接受左心耳封堵術的評估。預計這將促進左心耳封堵器銷量，並推動全球左心耳封堵器市場擴張。

提高識別高風險患者的準確性

提高識別血栓性栓塞症的準確性正在推動市場成長。隨著臨床醫生對左心耳血栓風險的了解不斷加深，越來越多的患者成為左心耳封堵術的候選人。

對於無法耐受長期抗凝血治療的患者或出血風險高的患者而言，這一點尤其重要。對於這些患者，左心耳封堵術可以作為降低中風風險的替代裝置。

預計患者識別準確率的增加將帶動預測期內手術數量的增加。隨著轉診途徑的完善以及更多心臟醫療團隊對左心耳封堵術候選患者進行評估，預計市場將持續成長至2032年。

心內膜裝置的應用

預計心內膜左心耳封堵器將佔據市場成長的大部分佔有率。這些裝置透過導管植入，通常比外科手術或心外膜封堵器創傷更小。

心內膜封堵術的微創特性促使醫師和醫院更廣泛地採用此術式。這也符合心血管領域在臨床適宜的情況下優先採用導管介入治療的大趨勢。

隨著監管核准的不斷推進、臨床證據的累積以及醫生對心內膜封堵器的理解不斷加深，其使用量預計將會增加。這將大大推動全球左心耳封堵器市場的成長。

市場限制

取決於技術的複雜程度和操作者的技能水平

無論是心內膜動脈封堵術或心外膜動脈封堵術，都需要經過專門訓練且經驗豐富的醫師操作。這限制了其在病例數量較少的醫療機構和新興醫療市場的應用。

心內膜介入手術需要先進的影像技術、房間隔穿刺、仔細選擇合適的器械尺寸以及精準的植入位置。心外膜介入手術也需要專業的術式知識，並且可能涉及更複雜的入路和外科團隊合作。

由於該方法高度依賴醫務人員，因此目前在擁有成熟結構性心臟疾病和心律不整治療方案的經驗豐富的醫療機構中，其應用最為廣泛。開展該手術所需的培訓和基礎設施建設仍將限制其普及。

先進診斷影像和多學科協作的要求

左心耳封堵術通常需要先進的影像技術和多學科心臟團隊的支援。影像檢查對於評估左心耳的解剖結構、指導封堵器放置以及確認封堵成功至關重要。

這會對缺乏必要設備、人員或流程協調的醫院造成障礙。在某些地區，診斷影像資源有限以及專科醫生短缺可能會導致實施延誤。

此外，協調護理路徑的需求也導致小規模醫療機構的治療數量減少。在更多醫療機構具備必要的配套設施之前，這種治療方法的引入可能仍將集中在治療量較大的項目中。

競爭加劇和贖回壓力

隨著左心耳封堵器陸續進入市場，預計競爭將加劇。雖然這將促進創新和產品應用，但從長遠來看，可能會對平均售價（ASP）造成壓力。

報銷條件也可能影響實施。醫院需要評估左心耳封堵術是否有明確的支付途徑支持，以及其是否具有足夠的經濟價值以證明擴大該項目的合理性。

這些因素可能會減緩推廣速度，尤其是在對成本敏感的醫療保健系統中，臨床證據、報銷或轉診途徑仍在發展中。

市場範圍和數據範圍

  • 量化範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
  • 定性範圍：市場促進因素和限制因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
  • 週期：基準年為 2025 年，預測至 2032 年，歷史資料至 2022 年。
  • 建立市場模型：收入分析採用銷售量和平均售價（ASP），並輔以治療量、競爭市場佔有率分析和預測假設。
  • 目標裝置：本報告涵蓋用於降低血栓性栓塞症風險的左心耳封堵裝置，包括心內膜、心外膜夾和心外膜縫合式左心耳封堵裝置。

目標市場及區隔

左心耳封堵器市場

  • 裝置類型：心內膜型、心外膜夾型及心外膜縫合型左心耳裝置。

心內膜左心耳封堵器是經由導管從心臟內部植入的。由於其應用範圍不斷擴大、植入方式微創以及臨床認可度高，預計這些裝置將佔據市場成長的很大一部分佔有率。

心外膜夾鉗裝置從心臟外部封閉或阻塞左心耳。這些產品常用於外科手術或需要體外閉合方法的場合。

心外膜心耳封堵器（LAA封堵器）採用縫合技術封閉左心耳。這些封堵器代表了左心耳治療的一種替代方法，並被納入更廣泛的醫療器材市場。

每個細分市場都按市場規模、市場佔有率、治療數量、市場預測、市場成長率、銷售量和平均售價進行分析。

這種市場細分有助於製造商、投資者和策略團隊了解手術方法、醫生採用率、患者選擇和設備類型如何影響全球左心耳封堵器市場。

競爭分析

截至2025年，波士頓科學公司在全球左心耳封堵器市場處於領先地位。該公司提供WATCHMAN™左心耳封堵器，作為一種經心內膜路徑的封堵選擇。

波士頓科學公司憑藉其WATCHMAN™裝置的廣泛應用和參與企業的高度認可，佔據了較大的市場佔有率。然而，一旦新的心內膜裝置獲得監管部門核准，該公司預計會失去部分市場佔有率。

2025 年，雅培是全球 LAA 市場第二大競爭對手。該公司提供「Amplatzer™ Amulet™ LAA 封堵器」作為其心內膜 LAA 裝置。

預計雅培公司未來幾年將擴大其市場佔有率，這主要得益於其Amplatzer™系列產品的良好口碑以及Amulet™產品的日益普及。該公司在結構性心臟疾病和封堵器械領域的豐富經驗也為其在心內膜左心耳封堵器領域的競爭力奠定了基礎。

2025年，AtriCure是全球左心耳封堵市場第三大競爭對手。該公司提供「AtriClip®」產品線，作為心外膜封堵方案。 「AtriClip®」產品線包含多種器械，使該公司在心外膜左心耳封堵領域擁有廣泛的產品系列。憑藉如此豐富的產品線，預計AtriCure將在未來幾年內保持其市場佔有率。

技術和臨床趨勢

左心耳內膜封堵術

預計心內膜左心耳封堵術仍將是市場成長的最大驅動力。這些裝置透過導管介入手術植入，因此比外科治療方法創傷更小。

這種方法與循環系統領域的大趨勢一致，強調對結構性心臟疾病進行微創治療。

心外膜夾閉術

心外膜夾閉術仍然是重要的治療選擇，尤其是在外科手術中。 AtriCure公司的AtriClip®產品系列就是這種方法的典型代表。

當臨床上需要對心耳進行外部縫合，或患者已經接受心臟手術時，可以使用心外膜縫合。

心外膜縫合閉合

基於心外膜縫合的裝置是左心耳（LAA）治療的另一種方法。由於這些技術利用器械實現了左心耳封堵，因此它們被納入更廣泛的市場範疇。

其作用取決於醫生的偏好、手術進行的環境以及患者的解剖結構。

識別心房顫動患者

由於對有發生左心耳相關血栓性栓塞症事件風險的心房顫動患者的識別能力提高，因此進行的手術數量增加。

隨著篩檢、轉診途徑和臨床意識的提高，可能會有更多患者被評估為左心耳封堵術的候選人。

從業人員培訓

左心耳封堵術需要訓練有素的外科醫生和經驗豐富的團隊。增加手術數量取決於醫生培訓、影像技術的進步以及多學科支援的擴展。

隨著越來越多的醫療機構實施 LAA 關閉計劃，培訓的重要性將保持不變。

與新參與企業的競爭

隨著心內膜器械監管核准的增加，左心耳封堵術市場預計將變得更加競爭激烈。雖然這將促進創新並擴大市場准入，但也可能對平均售價（ASP）造成壓力，並降低市場佔有率集中度。

擁有可靠的臨床數據、醫生培訓計劃和廣泛的銷售網路的公司預計將繼續處於最有利的地位。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球分析。

這份報告的意義

  • 目前全球左心耳封堵裝置的市場規模有多大？預計到 2032 年將成長多少？
  • 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
  • 左心耳封堵術在降低心房顫動患者血栓性栓塞症風險方面發揮什麼作用？
  • 對左心耳血栓風險的認知如何影響手術次數？
  • 為什麼預計心內膜左心耳封堵裝置將佔據市場成長的大部分佔有率？
  • 心內膜夾、心外膜夾及心外膜縫合裝置有何不同？
  • 根據技術的複雜性和對操作者的依賴程度，會出現哪些類型的障礙？
  • 診斷影像的要求以及對多學科協作團隊的需求對實施過程產生了哪些影響？
  • 全球左心耳封堵器市場的主要企業有哪些公司？
  • 在競爭格局中，波士頓科學公司、雅培公司和AtriCure公司處於什麼位置？

iData Research 的《全球左心耳封堵器市場報告》透過設備層面的分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。該報告可用於評估需求、對標競爭對手、了解左心耳封堵趨勢以及製定全球左心耳封堵器市場的產業計畫。

目錄

調查方法

  • 第一步：專案啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 第四步：進行初步調查
  • 第五步：調查與分析：建立基準估計值
  • 第六步：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

左心耳封堵器市場

  • 執行摘要
    • 全球左心耳封堵器市場概覽
    • 競爭分析
    • 目標程式
    • 目標市場
    • 目標區域
  • 介紹
  • 手術次數
    • 左心耳封堵器植入手術
    • 心內膜置入術
    • 心外膜裝置置入術
  • 市場概覽
    • 按細分市場
    • 按地區
  • 市場分析與預測
    • 左心耳封堵器整體市場
    • 心內膜左心耳植入裝置市場
    • 心外膜夾（LAA）器材市場
    • 心外膜縫合左心耳裝置市場
  • 促進因素和抑制因素
  • 競爭性市佔率分析

附錄

Product Code: iDATA_GLCS26_LAA_MC

Global Left Atrial Appendage Closure Device Market Report to 2032

The global left atrial appendage closure device market was valued at $2.3 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 10.5%, reaching $4.6 billion by 2032.

This report covers the global market for left atrial appendage (LAA) closure devices, including endocardial and epicardial LAA closure technologies.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by increasing awareness of LAA-related clot risk, improved identification of atrial fibrillation patients at risk of thromboembolic events, and broader adoption of device-based LAA closure. However, procedure complexity and operator dependency continue to limit adoption in lower-volume centers and emerging healthcare markets.

Market Overview

The global left atrial appendage closure device market includes devices used to close or exclude the left atrial appendage, a small pouch in the left atrium associated with thrombus formation in patients with atrial fibrillation.

LAA closure is used to reduce the risk of thromboembolic events in selected patients. These devices are especially relevant for patients with atrial fibrillation who are at elevated stroke risk and may not be ideal candidates for long-term anticoagulation therapy.

The market includes endocardial and epicardial devices. Endocardial devices are placed from inside the heart through a catheter-based approach, while epicardial devices close or exclude the appendage from the outside of the heart.

Growth in the LAA closure device market is supported by improved identification of patients with atrial fibrillation who are at risk of clot formation in the left atrial appendage. While both endocardial and epicardial devices are expected to see increased utilization, endocardial LAA closure devices are expected to account for the majority of market growth due to broader adoption and less invasive procedural approaches.

Market Drivers

LAA Awareness

Increasing awareness of the left atrial appendage and its role in thromboembolic risk is a major driver of the LAA closure device market. As more procedures are performed, awareness of LAA management and the available treatment options is expected to rise.

The WATCHMAN(TM) device helped generate positive publicity for LAA occlusion and increased awareness among physicians, hospitals, and patients. This awareness is expected to benefit all LAA closure devices with clinical data supporting their effectiveness.

As general awareness increases, more patients with atrial fibrillation may be evaluated for device-based LAA closure. This is expected to raise unit sales and apply upward pressure on the value of the global LAA closure device market.

Improved Identification of At-Risk Patients

Improved identification of atrial fibrillation patients at risk of thromboembolic events is supporting market growth. As clinicians better understand LAA-related clot risk, more patients are being evaluated for closure.

This is especially important for patients who cannot tolerate long-term anticoagulation or who face elevated bleeding risk. For these patients, LAA closure can offer a device-based alternative for stroke risk reduction.

Better patient identification is expected to increase procedural volumes over the forecast period. As referral pathways improve and more heart teams evaluate LAA closure candidates, the market is expected to expand steadily through 2032.

Endocardial Device Adoption

Endocardial LAA closure devices are expected to account for most market growth. These devices are placed through a catheter-based approach and are generally less invasive than surgical or epicardial alternatives.

The less invasive nature of endocardial closure supports broader physician and hospital adoption. It also aligns with wider cardiovascular trends favoring catheter-based treatment when clinically appropriate.

As endocardial devices gain regulatory approvals, clinical evidence, and physician familiarity, their utilization is expected to increase. This will support the majority of growth in the global LAA closure device market.

Market Limiters

Procedure Complexity and Operator Dependency

Both endocardial and epicardial LAA closure procedures require specialized training and experienced operators. This limits adoption in lower-volume centers and emerging healthcare markets.

Endocardial procedures require advanced imaging, transseptal access, careful device sizing, and precise placement. Epicardial approaches also require procedural expertise and may involve more complex access or surgical coordination.

Because of this operator dependency, adoption is strongest in experienced centers with established structural heart or electrophysiology programs. The need for training and procedural infrastructure will continue to limit broader use.

Advanced Imaging and Multidisciplinary Requirements

LAA closure procedures often require advanced imaging and multidisciplinary heart team support. Imaging is needed to assess appendage anatomy, guide device placement, and confirm closure success.

This creates barriers for hospitals that do not have the required equipment, staff, or procedural coordination. In some regions, limited imaging access or specialist availability may slow adoption.

The need for a coordinated care pathway can also reduce procedure volumes in smaller facilities. Until more centers build the necessary infrastructure, adoption will remain concentrated in higher-volume programs.

Competitive and Reimbursement Pressure

As more LAA closure devices enter the market, competition is expected to increase. While this can support innovation and wider availability, it may also place pressure on ASPs over time.

Reimbursement conditions can also affect adoption. Hospitals must evaluate whether LAA closure procedures are supported by clear payment pathways and whether the economic value is strong enough to justify program expansion.

These factors may slow adoption in cost-sensitive healthcare systems, especially where clinical evidence, reimbursement, or referral pathways are still developing.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
  • Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
  • Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
  • Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
  • Device scope: The report covers left atrial appendage closure devices used to reduce thromboembolic risk, including endocardial, epicardial clip, and epicardial suture LAA devices.

Markets Covered and Segmentation

Left Atrial Appendage Closure Device Market

  • Device type: Endocardial, epicardial clip, and epicardial suture LAA devices.

Endocardial LAA closure devices are placed from inside the heart through a catheter-based approach. These devices are expected to account for the majority of market growth due to broader adoption, less invasive delivery, and strong clinical awareness.

Epicardial clip devices close or exclude the left atrial appendage from the outside of the heart. These products are often used during surgical procedures or in settings where an external closure approach is preferred.

Epicardial suture LAA devices use suture-based methods to close the appendage. These devices represent another approach to LAA management and are included within the broader device market.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps manufacturers, investors, and strategy teams understand how procedural approach, physician adoption, patient selection, and device type are shaping the global LAA closure device market.

Competitive Analysis

Boston Scientific was the leader of the global LAA closure device market in 2025. The company offers the WATCHMAN(TM) LAA closure devices as an endocardial option.

Boston Scientific accounts for the majority of the market, supported by broad adoption of WATCHMAN(TM) and strong physician familiarity. However, once additional endocardial devices receive regulatory approval, the company is expected to lose some share to new entrants.

Abbott was the second-leading competitor in the global LAA market in 2025. The company offers the Amplatzer(TM) Amulet(TM) LAA Occluder as an endocardial LAA device.

Abbott is expected to grow its market share in the coming years due to the established use of the Amplatzer(TM) line and broader adoption of Amulet(TM). Its structural heart and closure device experience support its ability to compete in the endocardial LAA segment.

AtriCure was the third-leading competitor in the global LAA market in 2025. The company offers the AtriClip(R) product line as its epicardial option. The AtriClip(R) line includes multiple devices, giving the company an expansive portfolio within epicardial LAA closure. Because of this product breadth, AtriCure is expected to maintain its market share over the coming years.

Technology and Practice Trends

Endocardial LAA Closure

Endocardial LAA closure is expected to remain the largest source of market growth. These devices are delivered through catheter-based procedures and are less invasive than surgical alternatives.

This approach aligns with broader cardiovascular trends favoring minimally invasive structural heart interventions.

Epicardial Clip Closure

Epicardial clip closure remains an important option, especially in surgical settings. AtriCure's AtriClip(R) portfolio is a key example of this approach.

Epicardial closure may be used when external exclusion of the appendage is clinically preferred or when the patient is already undergoing a cardiac surgical procedure.

Epicardial Suture Closure

Epicardial suture-based devices represent another approach to LAA management. These technologies are included within the broader market because they offer a device-based method of appendage closure.

Their role depends on physician preference, procedural setting, and patient anatomy.

AFib Patient Identification

Improved identification of atrial fibrillation patients at risk of LAA-related thromboembolic events is supporting procedure growth.

As screening, referral pathways, and clinical awareness improve, more patients may be evaluated for LAA closure.

Operator Training

LAA closure requires trained operators and experienced teams. Procedure growth depends on the expansion of physician training, imaging expertise, and multidisciplinary support.

Training will remain important as more centers adopt LAA closure programs.

New Entrant Competition

The LAA closure market is expected to become more competitive as more endocardial devices gain regulatory approval. This may support innovation and broader access but could pressure ASPs and reduce share concentration.

Companies with strong clinical data, physician training programs, and broad distribution are expected to remain best positioned.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

  • How large is the global left atrial appendage closure device market today, and how much is it expected to grow through 2032?
  • How are unit sales, procedure numbers, ASPs, and market values changing over time?
  • What role does LAA closure play in reducing thromboembolic risk among atrial fibrillation patients?
  • How is awareness of LAA-related clot risk affecting procedure volumes?
  • Why are endocardial LAA closure devices expected to account for most market growth?
  • How do endocardial, epicardial clip, and epicardial suture devices differ?
  • What barriers are created by procedure complexity and operator dependency?
  • How do imaging requirements and multidisciplinary care teams affect adoption?
  • Which companies lead the global LAA closure device market?
  • How are Boston Scientific, Abbott, and AtriCure positioned in the competitive landscape?

The Global Left Atrial Appendage Closure Device Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand LAA closure trends, and support commercial planning in the global LAA closure device market.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Left Atrial Appendage Closure Device Market

  • 24.1 Executive Summary
    • 24.1.1 Global Left Atrial Appendage Closure Device Market Overview
    • 24.1.2 Competitive Analysis
    • 24.1.3 Procedures Included
    • 24.1.4 Markets Included
    • 24.1.5 Regions Included
  • 24.2 Introduction
  • 24.3 Procedure Numbers
    • 24.3.1 Total Left Atrial Appendage Closure Device Procedures
    • 24.3.2 Endocardial Device Procedures
    • 24.3.3 Epicardial Device Procedures
  • 24.4 Market Overview
    • 24.4.1 By Segment
    • 24.4.2 By Region
  • 24.5 Market Analysis And Forecast
    • 24.5.1 Total Left Atrial Appendage Closure Device Market
    • 24.5.2 Endocardial LAA Device Market
    • 24.5.3 Epicardial Clip LAA Device Market
    • 24.5.4 Epicardial Suture LAA Device Market
  • 24.6 Drivers And Limiters
    • 24.6.1 Market Drivers
    • 24.6.2 Market Limiters
  • 24.7 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

  • Chart 24-1: Left Atrial Appendage Closure Device Market, Global, 2025 & 2032
  • Chart 24-2: Left Atrial Appendage Closure Device Procedures, Global, 2025
  • Chart 24-3: Left Atrial Appendage Closure Device Procedures by Segment, Global, 2022 - 2032
  • Chart 24-4: Left Atrial Appendage Closure Device Market by Segment, Global, 2022 - 2032
  • Chart 24-5: Left Atrial Appendage Closure Device Market by Region, Global, 2022 - 2032
  • Chart 24-6: Leading Competitors, Left Atrial Appendage Closure Device Market, Global, 2025

LIST OF FIGURES

  • Figure 24-1: Left Atrial Appendage Closure Device Procedures Covered
  • Figure 24-2: Left Atrial Appendage Closure Device Markets Covered
  • Figure 24-3: Left Atrial Appendage Closure Device Regions Covered, Global (1 of 2)
  • Figure 24-4: Left Atrial Appendage Closure Device Regions Covered, Global (2 of 2)
  • Figure 24-5: Left Atrial Appendage Closure Device Procedures by Type, Global, 2022 - 2032
  • Figure 24-6: Left Atrial Appendage Closure Device Procedures by Region, Global, 2022 - 2032
  • Figure 24-7: Left Atrial Appendage Closure Device Procedures by Country, North America, 2022 - 2032
  • Figure 24-8: Left Atrial Appendage Closure Device Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 24-9: Left Atrial Appendage Closure Device Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 24-10: Left Atrial Appendage Closure Device Procedures by Country, Western Europe, 2022 - 2032
  • Figure 24-11: Left Atrial Appendage Closure Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 24-12: Left Atrial Appendage Closure Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 24-13: Left Atrial Appendage Closure Device Procedures by Country, Middle East, 2022 - 2032
  • Figure 24-14: Left Atrial Appendage Closure Device Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 24-15: Left Atrial Appendage Closure Device Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 24-16: Left Atrial Appendage Closure Device Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 24-17: Left Atrial Appendage Closure Device Procedures by Country, Africa, 2022 - 2032
  • Figure 24-18: Endocardial Device Procedures by Region, Global, 2022 - 2032
  • Figure 24-19: Endocardial Device Procedures by Country, North America, 2022 - 2032
  • Figure 24-20: Endocardial Device Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 24-21: Endocardial Device Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 24-22: Endocardial Device Procedures by Country, Western Europe, 2022 - 2032
  • Figure 24-23: Endocardial Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 24-24: Endocardial Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 24-25: Endocardial Device Procedures by Country, Middle East, 2022 - 2032
  • Figure 24-26: Endocardial Device Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 24-27: Endocardial Device Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 24-28: Endocardial Device Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 24-29: Endocardial Device Procedures by Country, Africa, 2022 - 2032
  • Figure 24-30: Epicardial Device Procedures by Region, Global, 2022 - 2032
  • Figure 24-31: Epicardial Device Procedures by Country, North America, 2022 - 2032
  • Figure 24-32: Epicardial Device Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 24-33: Epicardial Device Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 24-34: Epicardial Device Procedures by Country, Western Europe, 2022 - 2032
  • Figure 24-35: Epicardial Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 24-36: Epicardial Device Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 24-37: Epicardial Device Procedures by Country, Middle East, 2022 - 2032
  • Figure 24-38: Epicardial Device Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 24-39: Epicardial Device Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 24-40: Epicardial Device Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 24-41: Epicardial Device Procedures by Country, Africa, 2022 - 2032
  • Figure 24-42: Left Atrial Appendage Closure Device Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 24-43: Left Atrial Appendage Closure Device Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 24-44: Left Atrial Appendage Closure Device Market, Global, 2022 - 2032
  • Figure 24-45: Units Sold by Region, Left Atrial Appendage Closure Device Market, Global, 2022 - 2032
  • Figure 24-46: Average Selling Price by Region, Left Atrial Appendage Closure Device Market, Global, 2022 - 2032 (US$)
  • Figure 24-47: Market Value by Region, Left Atrial Appendage Closure Device Market, Global, 2022 - 2032 (US$M)
  • Figure 24-48: Endocardial LAA Device Market, Global, 2022 - 2032
  • Figure 24-49: Units Sold by Region, Endocardial LAA Device Market, Global, 2022 - 2032
  • Figure 24-50: Average Selling Price by Region, Endocardial LAA Device Market, Global, 2022 - 2032 (US$)
  • Figure 24-51: Market Value by Region, Endocardial LAA Device Market, Global, 2022 - 2032 (US$M)
  • Figure 24-52: Epicardial Clip LAA Device Market, Global, 2022 - 2032
  • Figure 24-53: Units Sold by Region, Epicardial Clip LAA Device Market, Global, 2022 - 2032
  • Figure 24-54: Average Selling Price by Region, Epicardial Clip LAA Device Market, Global, 2022 - 2032 (US$)
  • Figure 24-55: Market Value by Region, Epicardial Clip LAA Device Market, Global, 2022 - 2032 (US$M)
  • Figure 24-56: Epicardial Suture LAA Device Market, Global, 2022 - 2032
  • Figure 24-57: Units Sold by Region, Epicardial Suture LAA Device Market, Global, 2022 - 2032
  • Figure 24-58: Average Selling Price by Region, Epicardial Clip Suture Device Market, Global, 2022 - 2032 (US$)
  • Figure 24-59: Market Value by Region, Epicardial Clip Suture Device Market, Global, 2022 - 2032 (US$M)
  • Figure 24-60: Leading Competitors, Left Atrial Appendage Closure Device Market, Global, 2025